TVGN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Tevogen Bio Holdings Inc (TVGN.O) is -1.99, compared to its 5-year average forward P/E of -0.91. For a more detailed relative valuation and DCF analysis to assess Tevogen Bio Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.91

Current PE

-1.99

Overvalued PE

0.84

Undervalued PE

-2.66

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 140.46% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 140.46% over the last month.

Sold

Bought

TVGN News & Events

Events Timeline

No data

News

7.5

12-11Globenewswire

Tevogen Founder Donates 230,000 Shares to Local Police Benevolent Association

5.0

12-11Yahoo Finance

Tevogen CEO Donates 230,000 Shares of Common Stock to Support Local Law Enforcement

3.5

12-09Globenewswire

Tevogen Bio Recognizes Dr. Curtis Patton, Aims for Over $1 Billion Revenue

People Also Watch

Frequently Asked Questions

What is Tevogen Bio Holdings Inc (TVGN) stock price today?

The current price of TVGN is 0.395 USD — it has decreased -2.23 % in the last trading day.

What is Tevogen Bio Holdings Inc (TVGN)'s business?

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.

What is the price predicton of TVGN Stock?

Wall Street analysts forecast TVGN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TVGN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Tevogen Bio Holdings Inc (TVGN)'s revenue for the last quarter?

Tevogen Bio Holdings Inc revenue for the last quarter amounts to -5.73M USD, decreased -5.85 % YoY.

What is Tevogen Bio Holdings Inc (TVGN)'s earnings per share (EPS) for the last quarter?

Tevogen Bio Holdings Inc. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for Tevogen Bio Holdings Inc (TVGN)'s fundamentals?

The market is revising No Change the revenue expectations for Tevogen Bio Holdings Inc. (TVGN) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -53.09%.

How many employees does Tevogen Bio Holdings Inc (TVGN). have?

Tevogen Bio Holdings Inc (TVGN) has 18 emplpoyees as of December 15 2025.

What is Tevogen Bio Holdings Inc (TVGN) market cap?

Today TVGN has the market capitalization of 80.17M USD.